The Government extends its deepest sympathies to all those affected by pelvic mesh, and recognises the profound, life‑changing impact these harms have had on individuals and their families. We know that for many, the consequences are ongoing and deeply felt.

The Government is carefully considering the work done by the Patient Safety Commissioner (PSC), Professor Henrietta Hughes, including her report, which set out recommendations for redress for those harmed by sodium valproate and pelvic mesh.

The Government has been clear that there must be meaningful progress on this matter during this Parliament, although a decision to provide compensation has not yet been made. We recognise how difficult this uncertainty is for those affected, and we will ensure that the public is kept informed on this important work.

As you may be aware, the Department has been in contact with the PSC with regard to the ongoing health initiatives that the Department is taking forward in conjunction with NHS England, regarding sodium valproate and pelvic mesh. Details of the Government’s work to date are set out in recent letters to Professor Hughes, which are published on the PSC website, at the following link:

www.patientsafetycommissioner.org.uk

The Government extends its deepest sympathies to all those affected by pelvic mesh, and recognises the profound, life‑changing impact these harms have had on individuals and their families. We know that for many, the consequences are ongoing and deeply felt.

The Government is carefully considering the work done by the Patient Safety Commissioner (PSC), Professor Henrietta Hughes, including her report, which set out recommendations for redress for those harmed by sodium valproate and pelvic mesh. The Government has been clear that there must be meaningful progress on this matter during this Parliament. We recognise how difficult this uncertainty is for those affected, and we will ensure that the public is kept informed on this important work.

As you may be aware, the Department has been in contact with the PSC with regard to the ongoing health initiatives regarding sodium valproate and pelvic mesh. Details of the Government’s work to date are set out in recent letters to Professor Hughes, which are published on the PSC website, at the following link:

www.patientsafetycommissioner.org.uk

The Government extends its deepest sympathies to all those affected by pelvic mesh, and recognises the profound, life‑changing impact these harms have had on individuals and their families. We know that for many, the consequences are ongoing and deeply felt.

The Government is carefully considering the work done by the Patient Safety Commissioner (PSC), Professor Henrietta Hughes, including her report, which set out recommendations for redress for those harmed by sodium valproate and pelvic mesh. The Government has been clear that there must be meaningful progress on this matter during this Parliament. We recognise how difficult this uncertainty is for those affected, and we will ensure that the public is kept informed on this important work.

Departmental officials are working in coordination with colleagues across the Cabinet Office, HM Treasury, and the devolved administrations to establish the full scope of those affected by pelvic mesh, to assess the financial impact on individuals, and to develop our response to the PSC's report.

There are nine specialist mesh centres across England, ensuring that women in every region with complications resulting from mesh operations get the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need.

However, services can always improve. NHS England has now completed their internal audit of mesh centres across England conducted in 2025, which was designed in partnership with patient representatives. Though the audit is showing the value and impact of the service delivered by mesh centres, with nearly 3,000 patients now seen in the services since their introduction, equating to 700 per year, there are distinct areas for improvement and a timeline for these improvements will be made at pace.

The Government extends its deepest sympathies to all those affected by pelvic mesh, and recognises the profound, life‑changing impact these harms have had on individuals and their families. We know that for many, the consequences are ongoing and deeply felt.

The Government is carefully considering the work done by the Patient Safety Commissioner (PSC), Professor Henrietta Hughes, including her report, which set out recommendations for redress for those harmed by sodium valproate and pelvic mesh. The Government has been clear that there must be meaningful progress on this matter during this Parliament. We recognise how difficult this uncertainty is for those affected, and we will ensure that the public is kept informed on this important work.

Departmental officials are working in coordination with colleagues across the Cabinet Office, HM Treasury, and the devolved administrations to establish the full scope of those affected by pelvic mesh, to assess the financial impact on individuals, and to develop our response to the PSC's report.

There are nine specialist mesh centres across England, ensuring that women in every region with complications resulting from mesh operations get the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need.

However, services can always improve. NHS England has now completed their internal audit of mesh centres across England conducted in 2025, which was designed in partnership with patient representatives. Though the audit is showing the value and impact of the service delivered by mesh centres, with nearly 3,000 patients now seen in the services since their introduction, equating to 700 per year, there are distinct areas for improvement and a timeline for these improvements will be made at pace.

The Government extends its deepest sympathies to all those affected by pelvic mesh, and recognises the profound, life‑changing impact these harms have had on individuals and their families. We know that for many, the consequences are ongoing and deeply felt.

The Government is carefully considering the work done by the Patient Safety Commissioner (PSC), Professor Henrietta Hughes, including her report, which set out recommendations for redress for those harmed by sodium valproate and pelvic mesh. The Government has been clear that there must be meaningful progress on this matter during this Parliament. We recognise how difficult this uncertainty is for those affected, and we will ensure that the public is kept informed on this important work.

Departmental officials are working in coordination with colleagues across the Cabinet Office, HM Treasury, and the devolved administrations to establish the full scope of those affected by pelvic mesh, to assess the financial impact on individuals, and to develop our response to the PSC's report.

There are nine specialist mesh centres across England, ensuring that women in every region with complications resulting from mesh operations get the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need.

However, services can always improve. NHS England has now completed their internal audit of mesh centres across England conducted in 2025, which was designed in partnership with patient representatives. Though the audit is showing the value and impact of the service delivered by mesh centres, with nearly 3,000 patients now seen in the services since their introduction, equating to 700 per year, there are distinct areas for improvement and a timeline for these improvements will be made at pace.

The Government extends its deepest sympathies to all those affected by pelvic mesh, and recognises the profound, life‑changing impact these harms have had on individuals and their families. We know that for many, the consequences are ongoing and deeply felt.

The Government is carefully considering the work done by the Patient Safety Commissioner (PSC), Professor Henrietta Hughes, including her report, which set out recommendations for redress for those harmed by sodium valproate and pelvic mesh. The Government has been clear that there must be meaningful progress on this matter during this Parliament. We recognise how difficult this uncertainty is for those affected, and we will ensure that the public is kept informed on this important work.

Departmental officials are working in coordination with colleagues across the Cabinet Office, HM Treasury, and the devolved administrations to establish the full scope of those affected by pelvic mesh, to assess the financial impact on individuals, and to develop our response to the PSC's report.

There are nine specialist mesh centres across England, ensuring that women in every region with complications resulting from mesh operations get the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need.

However, services can always improve. NHS England has now completed their internal audit of mesh centres across England conducted in 2025, which was designed in partnership with patient representatives. Though the audit is showing the value and impact of the service delivered by mesh centres, with nearly 3,000 patients now seen in the services since their introduction, equating to 700 per year, there are distinct areas for improvement and a timeline for these improvements will be made at pace.

The Government extends its deepest sympathies to all those affected by pelvic mesh, and recognises the profound, life‑changing impact these harms have had on individuals and their families. We know that for many, the consequences are ongoing and deeply felt.

The Government is carefully considering the work done by the Patient Safety Commissioner (PSC), Professor Henrietta Hughes, including her report, which set out recommendations for redress for those harmed by sodium valproate and pelvic mesh. The Government has been clear that there must be meaningful progress on this matter during this Parliament. We recognise how difficult this uncertainty is for those affected, and we will ensure that the public is kept informed on this important work.

Departmental officials are working in coordination with colleagues across the Cabinet Office, HM Treasury, and the devolved administrations to establish the full scope of those affected by pelvic mesh, to assess the financial impact on individuals, and to develop our response to the PSC's report.

There are nine specialist mesh centres across England, ensuring that women in every region with complications resulting from mesh operations get the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need.

However, services can always improve. NHS England has now completed their internal audit of mesh centres across England conducted in 2025, which was designed in partnership with patient representatives. Though the audit is showing the value and impact of the service delivered by mesh centres, with nearly 3,000 patients now seen in the services since their introduction, equating to 700 per year, there are distinct areas for improvement and a timeline for these improvements will be made at pace.

The Patient Safety Commissioner wrote to the Prime Minister on 16 June, requesting information regarding internal and cross-Government discussions in relation to the Hughes Report, actions that have been taken beyond the Department, and the future plans regarding the implementation of its recommendations and a timetable for a full response.

The Department will provide any information required to support a timely response.

The Patient Safety Commissioner wrote to the Prime Minister on 16 June, requesting information regarding internal and cross-Government discussions in relation to the Hughes Report, actions that have been taken beyond the Department, and the future plans regarding the implementation of its recommendations and a timetable for a full response.

The Department will provide any information required to support a timely response.

The Patient Safety Commissioner wrote to the Prime Minister on 16 June, requesting information regarding internal and cross-Government discussions in relation to the Hughes Report, actions that have been taken beyond the Department, and the future plans regarding the implementation of its recommendations and a timetable for a full response.

The Department will provide any information required to support a timely response.

The Patient Safety Commissioner (PSC) wrote to the Prime Minister on 16 June, requesting information regarding internal and cross-Government discussions in relation to the Hughes Report, actions that have been taken beyond the Department, the future plans regarding the implementation of its recommendations, and a timetable for a full response.

The Department will provide any information required to support a timely response.

The Government extends its deepest sympathies to all those affected by pelvic mesh, and recognises the profound, life‑changing impact these harms have had on individuals and their families. We know that for many, the consequences are ongoing and deeply felt.

There are nine specialist mesh centres across England, ensuring that women in every region with complications of mesh inserted for urinary incontinence and vaginal prolapse get the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need.

The current service specification requirements include psychology services, which should be available. It also states that patients should be able to have follow up reviews for up to five years post-surgery. On discharge from the Specialised Mesh Service at five years, there will be clear instructions for the general practitioner to refer the person back if there are any new problems.

However, services can always improve. NHS England has now completed their internal audit of mesh centres across England conducted in 2025, which was designed in partnership with patient representatives. Though the audit is showing the value and impact of the service delivered by mesh centres, with nearly 3,000 patients now seen in the services since their introduction, equating to 700 per year, there are distinct areas for improvement and a timeline for these improvements will be made at pace.

The Government extends its deepest sympathies to all those affected by sodium valproate and pelvic mesh, and recognises the profound, life‑changing impact these harms have had on individuals and their families. We know that for many, the consequences are ongoing and deeply felt.

We are still in the process of considering the work done by the Patient Safety Commissioner and her report, which set out recommendations for redress for those that have been affected. This work takes time and we will respond once this work is complete.